Similar articles

• Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND). A Randomized Clinical Trial.

  Martinez FJ, Rabe KF, Sethi S, Pizzichini E, McIvor A, Anzueto A, Alagappan VK, Siddiqui S, Rekeda L, Miller CJ, Zetterstrand S, Reisner C, Rennard SI. Martinez FJ, et al. Am J Respir Crit Care Med. 2016 Sep 1;194(5):559-67. doi: 10.1164/rccm.201607-1349OC. Am J Respir Crit Care Med. 2016. PMID: 27585384 Clinical Trial.
• Intensified Therapy with Inhaled Corticosteroids and Long-Acting β₂-Agonists at the Onset of Upper Respiratory Tract Infection to Prevent Chronic Obstructive Pulmonary Disease Exacerbations. A Multicenter, Randomized, Double-Blind, Placebo-controlled Trial.

  Stolz D, Hirsch HH, Schilter D, Louis R, Rakic J, Boeck L, Papakonstantinou E, Schindler C, Grize L, Tamm M. Stolz D, et al. Am J Respir Crit Care Med. 2018 May 1;197(9):1136-1146. doi: 10.1164/rccm.201709-1807OC. Am J Respir Crit Care Med. 2018. PMID: 29266965 Clinical Trial.
• Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME Trial.

  Roche N, Chapman KR, Vogelmeier CF, Herth FJF, Thach C, Fogel R, Olsson P, Patalano F, Banerji D, Wedzicha JA. Roche N, et al. Am J Respir Crit Care Med. 2017 May 1;195(9):1189-1197. doi: 10.1164/rccm.201701-0193OC. Am J Respir Crit Care Med. 2017. PMID: 28278391 Clinical Trial.
• Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.

  [No authors listed] [No authors listed] Prescrire Int. 2016 Nov;25(176):272-277. Prescrire Int. 2016. PMID: 30715829 Review.
• Corticosteroid therapy and chronic obstructive pulmonary disease.

  MacIntyre NR. MacIntyre NR. Respir Care. 2006 Mar;51(3):289-96. Respir Care. 2006. PMID: 16533419 Review.